New FDA-Approved Treatment for RKD

The FDA has approved Gazyva® (Obinutuzumab) for Primary Membranous Nephropathy (pMN). Click here for more information. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Your Essential Guide to Navigating IgA Nephropathy

Please fill out this form to receive your free handbook.

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.